![]() Tanvex Biopharma Tanvex Biopharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs. | ![]() G1 Therapeutics G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. | ![]() Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics. | ![]() Bellicum Pharmaceuticals Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies. | ||||
Founding Date | Founding Date 1992 | Founding Date 2013 | Founding Date 2011 | Founding Date 2008 | Founding Date 1989 | Founding Date 2009 | Founding Date 2004 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||
Locations | Locations New Taipei City, TW HQ Irvine, US San Diego, US San Diego, US | Locations Cambridge, US HQ | Locations Durham, US HQ | Locations Carlsbad, US HQ | Locations West Lake Hills, US HQ Austin, US | Locations Houston, US HQ Houston, US Houston, US South San Francisco, US | |
Employees | Employees 1,2134% increase | Employees 1487% decrease | Employees 4116% decrease | Employees 12217% increase | Employees 7577% decrease | Employees 814% increase | Employees 10738% decrease |
Valuation ($) | Valuation ($) 436.8 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 287.4 m | Valuation ($) 5.6 b | Valuation ($) 64.5 m | Valuation ($) 10.9 m |
Twitter followers | Twitter followers 10.5 k | Twitter followers N/A | Twitter followers 476 | Twitter followers 1.3 k | Twitter followers 4.3 k | Twitter followers 2.1 k | Twitter followers 583 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 12 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 1 | Number of tweets (last 30 days) 11 | Number of tweets (last 30 days) 8 | Number of tweets (last 30 days) 4 | Number of tweets (last 30 days) 1 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 5.8 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 1.8 | Average likes per tweet (last 30 days) 6.4 | Average likes per tweet (last 30 days) 8.8 | Average likes per tweet (last 30 days) 2 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 63.64% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% |
Alexa Website Rank | Alexa Website Rank 438682 | Alexa Website Rank 309617 | Alexa Website Rank 324558 | Alexa Website Rank 411905 | Alexa Website Rank 333062 | Alexa Website Rank 386998 | Alexa Website Rank 421105 |
Employee Rating | Employee Rating 3.6 | Employee Rating 3.2 | Employee Rating 3.6 | Employee Rating 3.4 | Employee Rating 3.6 | Employee Rating N/A | Employee Rating 2.7 |
Financial | |||||||
Revenue (est.) | Revenue (est.) $3.7m (FY, 2021) | Revenue (est.) NT$5.4m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) $31.5m (FY, 2021) | Revenue (est.) $810.5m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods NT$1.9m (FY, 2021) | Cost of goods N/A | Cost of goods N/A | Cost of goods $10.8m (FY, 2021) | Cost of goods N/A | Cost of goods N/A |
Net income | Net income ($819.4m) (FY, 2021) | Net income (NT$1.5b) (FY, 2021) | Net income N/A | Net income ($148.4m) (FY, 2021) | Net income ($28.6m) (FY, 2021) | Net income ($19.6m) (FY, 2021) | Net income ($9.7m) (FY, 2021) |
Operating ⚠ | |||||||
Patents (US) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) 40 (FY, 2020) | Patents (US) 161 (Jun, 2021) | Patents (US) N/A | Patents (US) N/A |
Patents and Patent Applications | Patents and Patent Applications 1.2 k (FY, 2020) | Patents and Patent Applications N/A | Patents and Patent Applications N/A | Patents and Patent Applications 350 (FY, 2020) | Patents and Patent Applications N/A | Patents and Patent Applications N/A | Patents and Patent Applications N/A |
Funding | |||||||
Total funding raised | Total funding raised $ 409m | Total funding raised $ 346.9m | Total funding raised $ 200m | Total funding raised $ 289.6m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
Tanvex Biopharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.
View companyH3 Biomedicine is a biopharmaceutical company that specializes in cancer genomics.
View companyG1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.
View companyIonis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
View company